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Abstract
Background: Perioperative prophylactic antibiotic treatment significantly influences intestinal microflora, resulting
in impaired bowel functioning in some patients, sometimes requiring further investigations. This may lead to a
worse health-related quality of life (HRQoL). Probiotics administrated in the early post-operative period may help
avoiding such nuisances in older people.
Methods: We prospectively enrolled patients undergoing laparoscopic colorectal surgery aged over 70 years
between 2005 and 2012. The study was approved by IRB. All patients received perioperative antibiotic treatment.
Patients were randomized to one of two treatment arms: Group A patients received probiotics after surgery (VSL#3,
VSL Pharmaceuticals, Inc. USA - 900 × 109 daily, while Group B patients received a Placebo (cornstarch). Patients
were further divided in sub-groups whether ileo-caecal valve was spared or not. Patients were followed-up every
7 days for 4 weeks. Patients daily annotated bowel frequency, stool shape and consistency - according to Bristol’s
scale. HRQoL was assessed every week by means of SF-36 questionnaire.
Results: Group A included 10 while Group B included 8 patients. One patient in each group experienced a
postoperative complication. Group A patients had fewer bowel movements than controls, during every week. Stool
consistency was higher in patients undergoing resections including ileo-caecal valve receiving VSL#3. HRQoL
gradually increased in both groups; Group A patients had higher “social functioning” item scores at week 1 and 4
than controls.
Conclusions: Elderly patients undergoing resection of ileo-caecal valve may benefit from an early probiotics
administration pathway after perioperative antibiotic treatment.
Background
Intestinal microflora is profoundly influenced by antibiotic
therapy needed peri-operatively in patients undergoing
large bowel resections. The effects of short antibiotic ther-
apy on gut microbiota can last more than 24 months [1].
Elderly patients operated on may often suffer from
functional intestinal nuisances in the postoperative period,
which may require further investigations and treatments.
The possibility of modulating intestinal microflora by
means of probiotic formulations could potentially lead to a
better functioning of gut mucosal barrier, resulting in
reduced septic complications. Also, bowel control and
health-related quality of life (HRQoL) may be improved.
Aim of our study was to investigate whether the
administration of probiotics in the early postoperative
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period after large bowel resection can facilitate the
restoration of bowel function and reduce symptoms in
elderly patients.
Methods
This is a prospective double blind randomized trial on
patients aged over 70 years undergoing laparoscopic colo-
nic resection in our Unit between 2005 and January 2012.
The study was approved by IRB and all patients were
included after signing an informed consent. Patients were
randomly assigned to Group A (antibiotic + probiotic) or
Group B (antibiotic + placebo). In each group, patients
were further divided in sub-groups 1 and 2 whether sur-
gery preserved or not ileocaecal valve, respectively. After
the discharge, patients were seen in outpatient settings by
a resident every 7 days for 4 weeks. Neither patients nor
residents knew which treatment (probiotic/placebo) was
being administered.
Exclusion criteria
Dukes D colorectal cancer
Inflammatory bowel diseases
Need for temporary or definitive oostomy
Allergy to antibiotics/probiotics/placebo used in the
study
Perioperative antibiotic therapy
Patients received i.v. cefotaxime 1 g and i.v. metronidazole
1 g within 30 minutes from surgery, and continued on i.v.
cefotaxime 1g t.i.d. and i.v. metronidazole 500 mg t.i.d. for
no more than 24 hours postoperatively.
Probiotic/placebo therapy
Group A patients received probiotics (VSL#3, VSL Phar-
maceuticals, Inc. USA) at the dose of 900 × 109 daily,
divided in two administrations from one day after discon-
tinuation of antibiotic through four weeks. The probiotic
composition is the following: Streptococcus thermophilus
DSM 24731, Bifidobacteria (B. longum DSM 24736,
B. breve DSM 24732, B. infantis DSM 24737), Lattobacilli
(L. acidophilus DSM 24735, L. plantarum DSM 24730,
L. paracasei DSM 24733, L. delbrueckii subsp. bulgaricus
DSM 24734); maltose; silicium dioxide. Group B patients
received the Placebo composed of cornstarch (base ingre-
dient for probiotic product), indistinguishable from
VSL#3, in a similar fashion.
Bowel function assessment
During probiotic/placebo treatment patients were
requested to complete a daily report annotating: bowel
movement/s, body temperature, stool shape and consis-
tency. Stool characters were defined according to Bristol
scale [2], a 7-point scale in which stools were scored
according to cohesion and surface cracking, as follows:
1, separate hard lumps (like nuts); 2, sausage-shaped, but
lumpy; 3, like a sausage or snake, but with cracks on its
surface; 4, like a sausage or snake, and smooth and soft; 5,
soft blobs with a clear cut edge; 6, fluffy pieces with ragged
edges and mushy; and 7, watery with no solid pieces).
Quality of life assessment
Patients completed the SF-36 questionnaire every week
during probiotic/placebo treatment.
Statistical analysis
We enrolled all consecutive patients undergoing surgery in
the study period fitting inclusion criteria. Data are pre-
sented as mean ± SD. Categorical variable were compared
by means of Fisher’s exact test; for continuous parameters
Student’s t test was used.
Results
Group A included 10 patients (5 male); Group B included
8 patients (4 male). Patients characteristics and surgical
parameters are reported in Table 1. One patient in each
group experienced a postoperative complication, managed
conservatively. Irrespective of ileo-caecal valve preserva-
tion, Group A patients had fewer bowel movements than
controls, during every week (Figure 1).
No differences were observed concerning overall stool
consistency; however it was higher in patients undergoing
ileocolic resections including ileo-caecal valve receiving
VSL#3 (Figure 2).
No febrile episodes (body temperature ≥ 37.3° C) were
recorded.
Both groups showed a gradual increase in HRQoL from
first through fourth week; with respect to item “social









Age, yr (± SD) 71.5 (±2.1) 72.9 (±1.6) NS
BMI, kg/m2 (± SD) 21.5 (±3.9) 20.4 (±2.7) NS
Gender, n (M/F) 5/5 4/4 NS
Comorbidities, n (%) 8 (80) 7 (87.5) NS
ASA score ≥ III, n (%) 1 (10) 1 (12.5) NS
Operative time. min (± SD) 160.3 (±33.2) 155.8 (±41.1) NS
Procedure performed
Right hemicolectomy, n (%)






Complications*, n (%) 1 (10) 1 (12.5) NS
Length of stay, day (± SD) 12.0 (± 8.3) 13.5 (± 4.8) NS
SD: standard deviation
BMI: body mass index
ASA: American Society of Anaesthesiologists
* Group A: Prolonged ileus managed conservatively
Group B: Haemorrhage managed conservatively with blood transfusion
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functioning”, group A patients showed significantly
higher score at week 1 and 4 than patients receiving pla-
cebo (Figure 3).
No adverse effects to VSL#3 or placebo were observed.
Discussion
Perioperative antibiotic therapy, although demandable, are
responsible for relevant imbalances of intestinal micro-
biota [1,3]. This may lead to higher risk of infectious
Figure 1 Frequency of bowel movements in Group A (VSL#3) vs Group B (Placebo). Patients treated with probiotics had less mean bowel
moments/day at each week but the observation did not reach statistical significance (p = 0.06)
Figure 2 Bristol scores in subgroups of patients undergoing ileocaecal resections. Group A2 (VSL#3) patients had significantly higher
consistency stools than Group B2 (Placebo) patients throughout 4 weeks (p = 0.03)
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complications due to bacterial translocation. Also, the
imbalance in components of gut microflora is responsible
for intensified symptoms perception [1].
It has been reported that probiotic formulations are
not effective to reduce the rate of postoperative septic
complications in patients undergoing elective abdominal
surgery [3]. However, literature lacks studies investigat-
ing the effect of probiotics administration in the early
post-operative period on symptoms perception in elderly
patients undergoing large bowel resection.
In our series, we observed a lower frequency of evacua-
tions in patients receiving probiotics, although not statisti-
cally significant; stool consistency was slightly higher in
patients receiving resection not preserving ileo-caecal valve
treated with probiotics. HRQoL was comparable in both
groups, but patients in the probiotic group achieved a bet-
ter social functioning than controls at 1- and 4-week fol-
low-up.
Conclusions
Even if therapy with probiotics did not show a protective
effect on postoperative complications, frail patients under-
going resection of ileo-caecal valve may benefit from an
early probiotics administration pathway after perioperative
antibiotic treatment. Bowel frequency may be lower, irre-
spective of the type of surgery. These observations support
Figure 3 SF-36 quality of life items scores in Group A (VSL#3) vs Group B (Placebo). No differences were observed overall; at 1- and 4-
week follow-up, Group A patients showed significantly better social functioning (SF) than controls (p = 0.04 and p = 0.002).
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the usefulness of early probiotic administration in achiev-
ing a prompt restoration of function and return to every-
day activities.
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